Diagnostic Radiopharmaceuticals & Contrast Media

Diagnostic Radiopharmaceuticals & Contrast Media

Global Diagnostic Radiopharmaceuticals and Contrast Media Market to Reach $12.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Diagnostic Radiopharmaceuticals and Contrast Media estimated at US$9.4 Billion in the year 2020, is projected to reach a revised size of US$12.1 Billion by 2027, growing at aCAGR of 3.6% over the period 2020-2027. Radiopharmaceuticals, one of the segments analyzed in the report, is projected to record 3.5% CAGR and reach US$5.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Contrast Media segment is readjusted to a revised 3.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.5 Billion, While China is Forecast to Grow at 6.5% CAGR

The Diagnostic Radiopharmaceuticals and Contrast Media market in the U.S. is estimated at US$2.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2027 trailing a CAGR of 6.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.1% and 2.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Select Competitors (Total 38 Featured) -

  • AMAG Pharmaceuticals, Inc.
  • Bayer Healthcare AG
  • Bracco Imaging SpA
  • Daiichi Sankyo Co., Ltd.
  • GE Healthcare
  • Guerbet Group
  • Lantheus Holdings, Inc.
  • Mallinckrodt PLC
  • Medtronic PLC
  • Nordion, Inc.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
TABLE 4: World Current & Future Analysis for Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 7: World Current & Future Analysis for Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Contrast Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
TABLE 10: USA Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 11: USA Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 12: USA 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
CANADA
TABLE 13: Canada Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 14: Canada Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 15: Canada 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
JAPAN
TABLE 16: Japan Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 17: Japan Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 18: Japan 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
CHINA
TABLE 19: China Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 20: China Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 21: China 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
EUROPE
TABLE 22: Europe Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 23: Europe Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 24: Europe 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
TABLE 25: Europe Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 26: Europe Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 27: Europe 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
FRANCE
TABLE 28: France Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 29: France Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 30: France 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
GERMANY
TABLE 31: Germany Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 32: Germany Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 33: Germany 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
ITALY
TABLE 34: Italy Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 35: Italy Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 36: Italy 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
UNITED KINGDOM
TABLE 37: UK Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 38: UK Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 39: UK 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
SPAIN
TABLE 40: Spain Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 41: Spain Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 42: Spain 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
RUSSIA
TABLE 43: Russia Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 44: Russia Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 45: Russia 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
REST OF EUROPE
TABLE 46: Rest of Europe Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 47: Rest of Europe Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 48: Rest of Europe 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
ASIA-PACIFIC
TABLE 49: Asia-Pacific Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 50: Asia-Pacific Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 51: Asia-Pacific 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
TABLE 52: Asia-Pacific Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 53: Asia-Pacific Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 54: Asia-Pacific 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
AUSTRALIA
TABLE 55: Australia Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 56: Australia Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 57: Australia 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
INDIA
TABLE 58: India Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 59: India Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 60: India 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
SOUTH KOREA
TABLE 61: South Korea Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 62: South Korea Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 63: South Korea 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
TABLE 64: Rest of Asia-Pacific Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 65: Rest of Asia-Pacific Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 66: Rest of Asia-Pacific 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
LATIN AMERICA
TABLE 67: Latin America Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 68: Latin America Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 69: Latin America 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
TABLE 70: Latin America Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 71: Latin America Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 72: Latin America 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
ARGENTINA
TABLE 73: Argentina Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 74: Argentina Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 75: Argentina 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
BRAZIL
TABLE 76: Brazil Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 77: Brazil Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 78: Brazil 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
MEXICO
TABLE 79: Mexico Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 80: Mexico Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 81: Mexico 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
TABLE 82: Rest of Latin America Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 83: Rest of Latin America Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 84: Rest of Latin America 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
MIDDLE EAST
TABLE 85: Middle East Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 86: Middle East Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 87: Middle East 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
TABLE 88: Middle East Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 89: Middle East Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 90: Middle East 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
IRAN
TABLE 91: Iran Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 92: Iran Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 93: Iran 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
ISRAEL
TABLE 94: Israel Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 95: Israel Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 96: Israel 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
SAUDI ARABIA
TABLE 97: Saudi Arabia Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 98: Saudi Arabia Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 99: Saudi Arabia 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
TABLE 100: UAE Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 101: UAE Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 102: UAE 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
TABLE 103: Rest of Middle East Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 104: Rest of Middle East Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 105: Rest of Middle East 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
AFRICA
TABLE 106: Africa Current & Future Analysis for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 107: Africa Historic Review for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Radiopharmaceuticals and Contrast Media Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 108: Africa 15-Year Perspective for Diagnostic Radiopharmaceuticals & Contrast Media by Segment - Percentage Breakdown of Value Sales for Radiopharmaceuticals and Contrast Media for the Years 2012, 2020 & 2027
IV. COMPETITION
Total Companies Profiled: 38

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings